Novo Nordisk shares fall on weight-loss drug trial

Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.

Orignial Source:

https://www.foxbusiness.com/markets/novo-nordisk-shares-fall-weight-loss-drug-trial

Sidebar

Financial News

Novo Nordisk shares fall on weight-loss drug trial

National Weather